Blog & Resources Camargo Blog January 10th, 2008

PDUFA 2008—New Submisison Fees for 505(b)(2) Applications

FDA announced that for 2008 the full application fee for a 505(b)(2) that requires a clinical study will be $1,178,000. In addition, the establishment fee is $392,700 and the product fee is $65,030. Small businesses (defined as entities, including affiliates, with less than 500 employees) may request a waiver of the PDUFA review fee for first submission; subsequent submissions are paid at the current rates. All companies must pay the establishment and product fees.

For more information about user fees, see the FDA site.

Categories: Regulatory

Get Our Expertise Working for You

To learn how you can benefit from our regulatory and strategic development expertise, view our solutions or contact us.

Camargo Pharmaceutical Services provides comprehensive drug development solutions, specializing in customized programs including the 505(b)(2) pathway.

9825 Kenwood Road
Suite 203
Cincinnati OH, 45242
Durham Office
800 Taylor Street
Suite 101
Durham NC, 27701
Montreal Office
507 Place d'Armes
Suite 1101
Montreal, QC H2Y 2W8, Canada
Phone 513.561.3329
Toll Free 888.451.5708
Subscribe for our Latest Insights